A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living with small cell lung cancer (SCLC).

For 17 years, Ken Jones fought fires in San Francisco. Now, he is fighting cancer -- and the insurance company that insures ...

Projected losses in Medicaid coverage as a result of President Trump's "One Big Beautiful Bill" could result in more than 1 million missed cancer screenings and hundreds of avoidable deaths within 2 ...

Cancer’s cruelest trick is its ability to disappear, only to reappear years later in a new organ or a familiar scar. The fear ...

Experts discuss the critical unmet needs in HER2-mutant non-small cell lung cancer, highlighting disparities in testing and ...

Biomarker testing has become “increasingly critical” in the care of non-small cell lung cancer.A new investigation into testing rates proved “reassuring” to Kenneth L. Kehl, MD, MPH, assistant ...

In return for the rights to YL201 outside China, MediLink will receive upfront and potential near-term milestone payments ...

With most lung cancers in India diagnosed at advanced stages, experts say low-dose CT screening for high-risk groups like ...

The new artificial intelligence-based software and robot-assisted biopsy technology helps providers catch and treat lung cancer in its earliest stages.

How to lose weight in 2026 with the new Wegovy pill. Also in this month’s Your Health column: Is the super flu a real thing; ...

Zoldonrasib targets KRAS G12D-mutated non-small cell lung cancer, receiving FDA breakthrough therapy designation for its ...

New Medicaid eligibility rules may cause more than a million missed cancer screenings, and more than 100 preventable deaths, ...